Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Kevin Hamlin who wrote (993)	11/10/1998 1:48:00 PM
From: Wisee	of 1185

To All, Bob Rieder, CEO of Nortran, states in his shareholder's letter dated Oct. 20/98: "We are delighted to welcome Mr. Joseph Rus aboard, as our new Senior Director of Business Development. Mr. Rus, who most recently worked with F. Hoffman-LaRoche, brings over 25 years of international pharmaceutical industry experience to Nortran Pharmaceuticals, and will be responsible for all partnering and in-licensing activities". This is great news for Nortran. One has to ask, why would Mr. Rus quit (I presume) a comfortable job at Hoffman-LaRoche to join Nortran. Does he know something that we don't?? Wisee

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next